Impact of PCSK9 inhibitors in glycaemic control and new-onset diabetes.
González-Lleó AM, Sánchez-Hernández RM, Plana N, Ibarretxe D, Rehues P, Ribalta J, Llop D, Wägner AM, Masana L, Boronat M.
González-Lleó AM, et al. Among authors: wagner am.
Cardiovasc Diabetol. 2024 Jan 3;23(1):4. doi: 10.1186/s12933-023-02077-y.
Cardiovasc Diabetol. 2024.
PMID: 38172901
Free PMC article.